SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-280730
Filing Date
2021-09-23
Accepted
2021-09-23 16:30:59
Documents
18
Period of Report
2021-09-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d219285d8k.htm   iXBRL 8-K 31765
2 EX-1.1 d219285dex11.htm EX-1.1 196918
3 EX-5.1 d219285dex51.htm EX-5.1 7290
4 EX-99.1 d219285dex991.htm EX-99.1 7276
5 EX-99.2 d219285dex992.htm EX-99.2 7910
9 GRAPHIC g219285g0923035316119.jpg GRAPHIC 6545
10 GRAPHIC g219285g0923061925626.jpg GRAPHIC 6545
  Complete submission text file 0001193125-21-280730.txt   458167

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA sybx-20210922.xsd EX-101.SCH 2916
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE sybx-20210922_lab.xml EX-101.LAB 18139
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sybx-20210922_pre.xml EX-101.PRE 11424
11 EXTRACTED XBRL INSTANCE DOCUMENT d219285d8k_htm.xml XML 3366
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37566 | Film No.: 211272856
SIC: 2834 Pharmaceutical Preparations